Skip to main content

Surgery Partners CS(SGRY-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low13.28
Day High13.98
Open:13.70
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Surgery Partners CS

Select a category then submit the form to load news
Tipranks
Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM) and Surgery Partners (SGRY)
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Surgery Partners (SGRY), Stryker (SYK)
Tipranks
Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY) and MannKind (MNKD)
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surgery Partners (SGRY) and Keros Therapeutics (KROS)
Tipranks
RBC Capital Remains a Buy on Surgery Partners (SGRY)
StockStory
3 Russell 2000 Stocks with Questionable Fundamentals
CAKE
Tipranks
Surgery Partners Earnings Call Balances Growth And Strain
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Surgery Partners (SGRY) Receives a Hold from Barclays
Tipranks
Surgery Partners Announces Share Buyback and 2026 Outlook
StockStory
Surgery Partners’s (NASDAQ:SGRY) Q4 CY2025: Beats On Revenue But Stock Drops 18%
SGRY
GlobeNewswire
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2025 Results; Sets 2026 Guidance; Announces Share Repurchase Program
GlobeNewswire
Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Details
Motley Fool
Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million
StockStory
1 Cash-Producing Stock for Long-Term Investors and 2 We Find Risky
CRI
StockStory
2 Oversold Stocks Set for a Comeback and 1 We Turn Down
GWRE
StockStory
1 Healthcare Stock to Target This Week and 2 We Find Risky
AGL
StockStory
3 Small-Cap Stocks with Open Questions
LKQ
StockStory
3 Out-of-Favor Stocks We Find Risky
COTY
Tipranks
RBC Capital Keeps Their Buy Rating on Surgery Partners (SGRY)
Tipranks
Surgery Partners Issues $425M Senior Notes for Flexibility
StockStory
2 Healthcare Stocks on Our Watchlist and 1 We Brush Off
RMD
Tipranks
Surgery Partners Prices $425M Senior Notes Offering
Tipranks
Surgery Partners Announces $425M Senior Notes Offering
GlobeNewswire
Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
GlobeNewswire
Surgery Partners, Inc. Announces Add-On Senior Notes Offering
StockStory
1 Stock Under $50 with Exciting Potential and 2 We Turn Down
LIND
GlobeNewswire
Surgery Partners and Baylor Scott & White Health Form Joint Venture to Expand Access to Quality Care
StockStory
3 Cash-Producing Stocks We Find Risky
COTY
StockStory
1 of Wall Street’s Favorite Stock Worth Your Attention and 2 We Find Risky
LFUS
StockStory
Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know
ALHC
Tipranks
Barclays Keeps Their Hold Rating on Surgery Partners (SGRY)

Profile

Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.